Interactive Investor
>>

Avacta Group (LSE:AVCT) Share Price

AVCT

Avacta Group

UK company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XLON

-

Updated: -

Research

News & analysis

Regulatory news

Loading...

Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and pre|CISION tumor-targeted chemotherapy. The company operates in the United Kingdom, Rest of Europe, Asia, and North America.Avacta Group PLC is a United Kingdom based company, which caters to the healthcare sector. It develops medical diagnostic products such as reagents and arrays which are helpful in drug discovery.

LSE:AVCT

GB00BYYW9G87

GBX

Loading...

Loading Comparison

Latest AVCT News

AVCT Regulatory News